Skip to content
Screener

CeriBell, Inc. CBLL Common Stock

Common Stock at other companies

IAR
Integra LifeSciencesIART
240M0.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
90M0.0%
iRadimed logo
iRadimedIRMD
31.5M+2,476,315%
Teladoc Health logo
Teladoc HealthTDOC
300M0.0%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
100M0.0%
ICU Medical logo
ICU MedicalICUI
80M0.0%

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574
Line itemJune 30, 2026December 31, 2025
Issued and outstanding shares: none as of June 30, 2026 and December 31, 2025, respectively
Common stock, $0.001 par value;
Authorized shares: 500,000,000 as of June 30, 2026 and December 31, 2025, respectively
Issued and outstanding shares: 38,223,221 and 37,485,124 as of June 30, 2026 and December 31, 2025, respectively3938
Additional paid-in capital387,727375,495
Accumulated other comprehensive income (loss)(92)159
Accumulated deficit(259,361)(220,356)
Total stockholders’ equity128,313155,336

Item 1. Financial Statements.

FAQ

What is CeriBell, Inc.'s common stock?
CeriBell, Inc. (CBLL) reported common stock of $39K in Q2 2026.
How has CeriBell, Inc.'s common stock changed year-over-year?
CeriBell, Inc.'s common stock increased by 5.4% year-over-year, from $37K to $39K.
What is the long-term trend for CeriBell, Inc.'s common stock?
Over 2 years (2023 to 2025), CeriBell, Inc.'s common stock has grown at a 175.7% compound annual growth rate (CAGR), from $5K to $38K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about CeriBell, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude